Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenbin Cao

Showing results (71-80 of 109) with videos related to

Pageof 11
Sort By:
Scientific Data|June 4, 2024
Single-cell transcriptome atlas of testes from mice with high-fat dietsWenbin Cao, Yulin Zhang, Jia Qi, et al.
Angewandte Chemie (International Ed. in English)|April 16, 2024
Breaking Highly Ordered PtPbBi Intermetallic with Disordered Amorphous Phase for Boosting Electrocatalytic Hydrogen Evolution and Alcohol OxidationFukai Feng, Chaoqun Ma, Sumei Han, et al.
Advanced Materials (Deerfield Beach, Fla.)|March 3, 2025
Incorporating Ordered Indium Sites into Rhodium for Ultra-Low Potential Electrocatalytic Conversion of Ethylene Glycol to Glycolic AcidCaihong He, Yifan Yan, Yu Fu, et al.
Physical Review. E|July 24, 2019
Diversity of collective migration patterns of invasive breast cancer cells emerging during microtrack invasionRuchuan Liu, Kena Song, Zhijian Hu, et al.
American Journal of Hematology|August 6, 2025
Efficacy and Safety of the Third-Generation Tyrosine Kinase Inhibitor Olverembatinib in Combination With Inotuzumab Ozogamicin for the Treatment of Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Patients With Refractory/Relapsed Disease or Persistent Minimal Residual Disease Bridging to Hematopoietic Stem Cell TransplantationXiaoyu Zhang, Yigeng Cao, Jialin Wei, et al.
Genomics|October 17, 2024
Characterization of small RNAs in the spleen of MASH in a non-human primate modelJuan Zhao, Yuelei Zhao, Hongyu Qin, et al.
Journal of the American Chemical Society|May 20, 2024
Heterophase Intermetallic Compounds for Electrocatalytic Hydrogen Production at Industrial-Scale Current DensitiesXiao Ma, Chaoqun Ma, Jing Xia, et al.
Bone Marrow Transplantation|May 9, 2025
Divergent prognostic factors in high-risk vs. standard-risk patients aged 50-65 years after allo-HCT for AML/MDS: a single-center retrospective analysisWenwen Guo, Haixiao Zhang, Hongye Gao, et al.
Frontiers in Immunology|July 21, 2025
Impact of pre-transplant body mass index on outcomes in AML patients aged ≥ 50 years after allogeneic hematopoietic cell transplantationWenwen Guo, Haixiao Zhang, Hongye Gao, et al.
Annals of Hematology|December 13, 2025
Targeting relapsed/refractory and MRD + Ph + ALL: olverembatinib-venetoclax bridging enhances allo-HSCT outcome​Xiaoyu Zhang, Yanhong Zhao, Weihua Zhai, et al.
Pageof 11

Showing results (71-80 of 109) with videos related to

Sort By:
Pageof 11
Scientific Data|June 4, 2024
Single-cell transcriptome atlas of testes from mice with high-fat dietsWenbin Cao, Yulin Zhang, Jia Qi, et al.
Angewandte Chemie (International Ed. in English)|April 16, 2024
Breaking Highly Ordered PtPbBi Intermetallic with Disordered Amorphous Phase for Boosting Electrocatalytic Hydrogen Evolution and Alcohol OxidationFukai Feng, Chaoqun Ma, Sumei Han, et al.
Advanced Materials (Deerfield Beach, Fla.)|March 3, 2025
Incorporating Ordered Indium Sites into Rhodium for Ultra-Low Potential Electrocatalytic Conversion of Ethylene Glycol to Glycolic AcidCaihong He, Yifan Yan, Yu Fu, et al.
Physical Review. E|July 24, 2019
Diversity of collective migration patterns of invasive breast cancer cells emerging during microtrack invasionRuchuan Liu, Kena Song, Zhijian Hu, et al.
American Journal of Hematology|August 6, 2025
Efficacy and Safety of the Third-Generation Tyrosine Kinase Inhibitor Olverembatinib in Combination With Inotuzumab Ozogamicin for the Treatment of Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Patients With Refractory/Relapsed Disease or Persistent Minimal Residual Disease Bridging to Hematopoietic Stem Cell TransplantationXiaoyu Zhang, Yigeng Cao, Jialin Wei, et al.
Genomics|October 17, 2024
Characterization of small RNAs in the spleen of MASH in a non-human primate modelJuan Zhao, Yuelei Zhao, Hongyu Qin, et al.
Journal of the American Chemical Society|May 20, 2024
Heterophase Intermetallic Compounds for Electrocatalytic Hydrogen Production at Industrial-Scale Current DensitiesXiao Ma, Chaoqun Ma, Jing Xia, et al.
Bone Marrow Transplantation|May 9, 2025
Divergent prognostic factors in high-risk vs. standard-risk patients aged 50-65 years after allo-HCT for AML/MDS: a single-center retrospective analysisWenwen Guo, Haixiao Zhang, Hongye Gao, et al.
Frontiers in Immunology|July 21, 2025
Impact of pre-transplant body mass index on outcomes in AML patients aged ≥ 50 years after allogeneic hematopoietic cell transplantationWenwen Guo, Haixiao Zhang, Hongye Gao, et al.
Annals of Hematology|December 13, 2025
Targeting relapsed/refractory and MRD + Ph + ALL: olverembatinib-venetoclax bridging enhances allo-HSCT outcome​Xiaoyu Zhang, Yanhong Zhao, Weihua Zhai, et al.
Pageof 11